Nielsen DL - Search Results

1

Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group.

Nielsen DL, Bjerre KD, Jakobsen EH, Cold S, Stenbygaard L, Sørensen PG, Kamby C, Møller S, Jørgensen CL, Andersson M. Nielsen DL, et al. J Clin Oncol. 2011 Dec 20;29(36):4748-54. doi: 10.1200/JCO.2010.33.9507. Epub 2011 Nov 14. J Clin Oncol. 2011. PMID: 22084374 Clinical Trial.

2

Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method.

Svane IM, Nikolajsen K, Hansen SW, Kamby C, Nielsen DL, Johnsen HE. Svane IM, et al. Among authors: nielsen dl. Bone Marrow Transplant. 2002 Apr;29(8):659-66. doi: 10.1038/sj.bmt.1703521. Bone Marrow Transplant. 2002. PMID: 12180110

3

[Radiotherapy of primary breast cancer. An analysis of a systematic Cochrane review].

Nielsen DL, Kamby C. Nielsen DL, et al. Ugeskr Laeger. 2003 Jan 13;165(3):219-21. Ugeskr Laeger. 2003. PMID: 12555702 Danish. No abstract available.

4

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.

Svane IM, Pedersen AE, Johnsen HE, Nielsen D, Kamby C, Gaarsdal E, Nikolajsen K, Buus S, Claesson MH. Svane IM, et al. Cancer Immunol Immunother. 2004 Jul;53(7):633-41. doi: 10.1007/s00262-003-0493-5. Epub 2004 Feb 25. Cancer Immunol Immunother. 2004. PMID: 14985857 Free PMC article. Clinical Trial.

5

Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy.

Ryberg M, Nielsen D, Osterlind K, Andersen PK, Skovsgaard T, Dombernowsky P. Ryberg M, et al. Breast Cancer Res Treat. 2005 Jun;91(3):217-25. doi: 10.1007/s10549-005-0323-x. Breast Cancer Res Treat. 2005. PMID: 15952055 Clinical Trial.

6

[Taxanes in metastatic breast cancer. An analysis of a systematic Cochrane review].

Nielsen DL, Kamby C. Nielsen DL, et al. Ugeskr Laeger. 2006 Sep 11;168(37):3117-20. Ugeskr Laeger. 2006. PMID: 16999914 Review. Danish. No abstract available.

7

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.

Svane IM, Pedersen AE, Johansen JS, Johnsen HE, Nielsen D, Kamby C, Ottesen S, Balslev E, Gaarsdal E, Nikolajsen K, Claesson MH. Svane IM, et al. Cancer Immunol Immunother. 2007 Sep;56(9):1485-99. doi: 10.1007/s00262-007-0293-4. Epub 2007 Feb 7. Cancer Immunol Immunother. 2007. PMID: 17285289 Free PMC article. Clinical Trial.

8

[Medical, non-endocrine treatment of metastatic breast cancer--a status].

Lindberg H, Nielsen DL, Kamby C. Lindberg H, et al. Among authors: nielsen dl. Ugeskr Laeger. 2007 Apr 23;169(17):1556-60. Ugeskr Laeger. 2007. PMID: 17484824 Review. Danish.

9

[Neoadjuvant antihormonal treatment of women with breast cancer].

Tuxen MK, Kamby C, Nielsen DL. Tuxen MK, et al. Among authors: nielsen dl. Ugeskr Laeger. 2007 Sep 10;169(37):3077-81. Ugeskr Laeger. 2007. PMID: 17877952 Review. Danish.

10

[Medical treatment of primary breast cancer: new targeted biological treatments].

Andersson M, Nielsen DL. Andersson M, et al. Among authors: nielsen dl. Ugeskr Laeger. 2007 Sep 10;169(37):3082-4. Ugeskr Laeger. 2007. PMID: 17877953 Danish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page